Skip to main content
lexblog.com/lib/HWFKFA40viewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA and EMA Provide Guiding Principles for AI in Drug Development",
    "url": "https://www.lexblog.com/2026/01/27/fda-and-ema-provide-guiding-principles-for-ai-in-drug-development/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-HWFKFA40",
        "url": "https://www.lexblog.com/lib/HWFKFA40/"
    },
    "datePublished": "2026-01-27T15:29:52-05:00",
    "dateModified": "2026-01-27T12:32:12-05:00",
    "author": {
        "@type": "Person",
        "name": "Craig B. Bleifer, Allyson M. Maur, Jessica L. Vaughn, Ph.D., Bryan S. Walsh"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "McGuireWoods LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Password Protected",
    "about": "Health Care and Life Sciences ยท Technology and AI",
    "sourceUrl": "https://www.passwordprotectedlaw.com/?p=6117",
    "sourceStability": "may-move"
}